Reviews: Review ArticleCurrent Concepts in the Management of Trigger Finger in AdultsGil, Joseph A. MD; Hresko, Andrew M. MD; Weiss, Arnold-Peter C. MDAuthor Information From the Department of Orthopaedic Surgery, Alpert Medical School of Brown University, Providence, RI. None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Gil, Dr. Hresko, and Dr. Weiss. Journal of the American Academy of Orthopaedic Surgeons: August 1, 2020 - Volume 28 - Issue 15 - p e642-e650 doi: 10.5435/JAAOS-D-19-00614 Metrics Abstract Trigger finger (TF) is one of the most common causes of hand disability. Immobilization of TF with a joint-blocking orthosis has been demonstrated to effectively relieve pain and improve function. The efficacy of steroid injections for TF varies based on the number of affected digits and the clinical severity of the condition. Up to three repeat steroid injections are effective in most patients. When conservative interventions are unsuccessful, open surgical release of the A1 pulley effectively alleviates the subjective and objective manifestations of TF and currently remains the benchmark procedure for addressing TF. Although several studies have emerged suggesting that a percutaneous approach may result in improved outcomes, this technique demands a learning curve that may predispose patients to higher risk of procedure-related complications. There is no role for preoperative antibiotics in patients who undergo elective soft-tissue procedures of the hand. WALANT anesthesia has gained popularity because it has been associated with improved patient outcomes and a clear cost savings; however, proper patient selection is critical. Similar to other soft-tissue hand procedures, TF surgery rarely necessitates a postoperative opioid prescription. Copyright 2020 by the American Academy of Orthopaedic Surgeons.